Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nim Lalvani"'
Autor:
Christopher Gottschalk, Anirban Basu, Andrew Blumenfeld, Bradley Torphy, Michael J Marmura, Jelena M Pavlovic, Paula K Dumas, Nim Lalvani, Dawn C Buse
Publikováno v:
Cephalalgia Reports, Vol 5 (2022)
Background: Newly approved migraine preventive therapies have allowed for rapid control of migraine activity, offering potential to minimize the burden of migraine. This report summarizes a roundtable discussion convened to analyze evidence for early
Externí odkaz:
https://doaj.org/article/f11e68cc8f44401b92a7467f0fdd780f
Autor:
Christopher Gottschalk, Dawn C. Buse, Michael J. Marmura, Bradley Torphy, Jelena M. Pavlovic, Paula K. Dumas, Nim Lalvani, Andrew Blumenfeld
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Recently approved migraine preventive therapies facilitate rapid control of migraine activity, potentially improving patients’ lives and minimizing the societal burden of migraine. This review synthesizes available evidence on rates and timing of e
Externí odkaz:
https://doaj.org/article/03c24a5f7cd2431298b9b159917a7ede
Autor:
Chia-Chun Chiang, Ken Shubin Stein, David W. Dodick, Nim Lalvani, Rashmi B. Halker Singh, Lawrence C. Newman, Deborah Henscheid Lorenz, Christine Lay
Publikováno v:
Headache
Objective We sought to investigate the patient experience of telemedicine for headache care during the coronavirus disease 2019 (COVID‐19) pandemic. Background The use of telemedicine has rapidly expanded and evolved since the beginning of the COVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d14397483912632c41045f928f5eab
https://doi.org/10.1111/head.14110
https://doi.org/10.1111/head.14110
Autor:
David W. Dodick, Jes Olesen, Mark J. Burish, Richard B. Lipton, Audrey Craven, Peter J. Goadsby, Nim Lalvani, Gina Dumkrieger, Stephen D. Silberstein, Ryotaro Ishii, Todd J. Schwedt
Publikováno v:
HeadacheREFERENCES. 61(7)
OBJECTIVE To evaluate whether the 15-day threshold of headache days per month adequately reflects substantial differences in disability across the full spectrum of migraine. BACKGROUND The monthly frequency of headache days defines migraine subtypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad051dcfee1f511fca1d8f27377bddec
https://pubmed.ncbi.nlm.nih.gov/34601727
https://pubmed.ncbi.nlm.nih.gov/34601727